The G20210A polymorphism of the prothrombin gene is the strong genetic risk factor for the pulmonary embolism development in young patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004
The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Source: Eur Respir J 2002; 19: 709-711 Year: 2002
The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020 Year: 2020
Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
Massive pulmonary embolism as the first manifestation in a patient with double heterozygocity for MTHFR and prothrombin 20210 G/A Source: Eur Respir J 2003; 22: Suppl. 45, 443s Year: 2003
Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL) Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
The genetic polymorphisms associated with acute pulmonary embolism (PE) and deep venous thrombosis (DVT) Source: Eur Respir J 2001; 18: Suppl. 33, 381s Year: 2001
Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 736-741 Year: 2008
The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010
Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006
Inherited thrombophilic risk factors in venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002
Genetic and acquired risk factors of venous thromboembolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=1 Year: 2004
Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007
Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
The acquired and inherited risk factors in venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
Prothrombin 20210 G/A mutation and EPCR I/D polymorphisms were rare in patients with pulmonary thromboembolism in Chinese Han population Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Age is a major risk factor of venous thromboembolism (VTE) Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005